Hepatitis B Virus Reactivation in Cancer Patients Receiving Direct-acting Antivirals for Hepatitis C Virus Infection

Overview

Journal J Viral Hepat

Specialty Gastroenterology

Date 2021 Feb 1

PMID 33523503

Authors

Haley Pritchard

Jessica P Hwang

Georgios Angelidakis

Marcel Yibirin

Lan Wang

Ethan Miller

Harrys A Torres

Affiliations

Soon will be listed here.

References

Mucke M, Backus L, Mucke V, Coppola N, Preda C, Yeh M . Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2018; 3(3):172-180. DOI: 10.1016/S2468-1253(18)30002-5. View

Torres H, Pundhir P, Mallet V . Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis. Gastroenterology. 2019; 157(4):909-916. DOI: 10.1053/j.gastro.2019.01.271. View

Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J . Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009; 15(10):1143-238. PMC: 3103296. DOI: 10.1016/j.bbmt.2009.06.019. View

Torres H, Economides M, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P . Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2018; 114(2):250-257. DOI: 10.1038/s41395-018-0383-2. View

Pawlowska M, Flisiak R, Gil L, Horban A, Hus I, Jaroszewicz J . Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation. Clin Exp Hepatol. 2019; 5(3):195-202. PMC: 6781818. DOI: 10.5114/ceh.2019.87631. View

Hwang J, Somerfield M, Alston-Johnson D, Cryer D, Feld J, Kramer B . Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Clin Oncol. 2015; 33(19):2212-20. PMC: 4477791. DOI: 10.1200/JCO.2015.61.3745. View

Terrault N, Lok A, McMahon B, Chang K, Hwang J, Jonas M . Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018; 67(4):1560-1599. PMC: 5975958. DOI: 10.1002/hep.29800. View

Wang J, Hu C, Chen Y, Liu Z, Yu Q, Yang S . HBV reactivation during direct-acting antiviral therapy in hepatitis B and C coinfected patients undergoing haemodialysis. Antivir Ther. 2019; 24(2):77-84. DOI: 10.3851/IMP3292. View

Torres H, Davila M . Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 2012; 9(3):156-66. DOI: 10.1038/nrclinonc.2012.1. View

10.

Hwang J, Lok A . Management of patients with hepatitis B who require immunosuppressive therapy. Nat Rev Gastroenterol Hepatol. 2013; 11(4):209-19. PMC: 4170710. DOI: 10.1038/nrgastro.2013.216. View

11.

. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2018; 67(10):1477-1492. PMC: 7190892. DOI: 10.1093/cid/ciy585. View

12.

Belperio P, Shahoumian T, Mole L, Backus L . Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals. Hepatology. 2017; 66(1):27-36. DOI: 10.1002/hep.29135. View

13.

Yeh M, Huang C, Huang C, Holmes J, Hsieh M, Tsai Y . Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection. J Hepatol. 2020; 73(1):62-71. DOI: 10.1016/j.jhep.2020.01.027. View

14.

Pockros P . Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection. Gastroenterol Hepatol (N Y). 2017; 13(9):536-540. PMC: 5635429. View